GlaxoSmithKline Receives Anthrax Treatment Contract

 British drugmaker GlaxoSmithKline announced Thursday that it has landed a four-year contract to supply an anthrax treatment to the U.S. government for use as a counter measure to a potential bioterrorist attack.